Clinical Trials Browser

Phase 1 × Kidney Neoplasms × peginterferon alfa-2b × Clear all

NCT00589550 2015-06-08

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 1 Terminated

1 enrolled 2 charts

Carcinoma, Renal Cell, Kidney Neoplasms